Liquid biopsy may unlock genetic secrets of brain AVMs
NCT ID NCT07103304
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study will analyze blood samples from the drainage vein of brain arteriovenous malformations (AVMs) in 16 adults undergoing embolization. The goal is to identify genetic mutations that may drive these abnormal vessels. Understanding these mutations could pave the way for future targeted drug treatments, but this research is purely observational and does not test any therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward targeted drug therapies for brain arteriovenous malformations, potentially reducing the need for invasive procedures.
- What could go wrong
- This is a very small, early-stage observational study (16 participants) that only looks for genetic mutations. It does not test any treatment, so benefits are uncertain and far off.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL ARTERIOVENOUS MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital la Pitié-Salpêtrière
Paris, 75013, France
-
University Hospital of Caen
Caen, 14033, France
-
University Hospital of Rouen
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.